Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases
- 1 December 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in European Journal of Gastroenterology & Hepatology
- Vol. 20 (12), 1182-1193
- https://doi.org/10.1097/meg.0b013e3283036768
Abstract
Background/Aims Hepatotoxicity has been previously suspected by national regulatory agencies in 26 patients in causal relationship with the treatment by kava extracts commonly used as herbal anxiolytic drugs. Methods A quantitative causality assessment was undertaken using the system of the Council for International Organizations of Medical Sciences, scale of objective probability scoring. Results Causality was unassessable, unrelated, or excluded in 16 patients owing to lack of temporal association and causes independent of kava or comedicated drugs. Low Council for International Organizations of Medical Sciences scores additionally resulted in excluded or unlikely causality assessments (n=2), leaving a total of eight patients with various degrees of causality for kava ± comedicated drugs. Only one out of these eight patients adhered to the regulatory recommendations regarding both daily dose (≤120 mg kavapyrones) and duration of therapy (≤3 months) and experienced toxic liver injury with a probable causality for kava. In six cases with kava overdose and/or increased duration of kava treatment causality for kava was possible (n=3) and for kava together with the comedicated drug(s) possible (n=2) or probable (n=1). Conclusion Kava taken as recommended is associated with rare hepatotoxicity, whereas overdose, prolonged treatment, and comedication may carry an increased risk.Keywords
This publication has 40 references indexed in Scilit:
- Drug-induced liver diseaseCurrent Opinion in Gastroenterology, 2006
- Drug-induced liver injury: Summary of a single topic clinical research conferenceHepatology, 2006
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Causality assessment in drug-induced hepatotoxicityExpert Opinion on Drug Safety, 2004
- Acute and clinically relevant drug‐induced liver injury: a population based case‐control studyBritish Journal of Clinical Pharmacology, 2004
- Safety and Efficacy of Herbal Sedatives in Cancer CareIntegrative Cancer Therapies, 2004
- Kava kava: examining new reports of toxicityToxicology Letters, 2004
- Clinical Perspectives on Xenobiotic‐Induced HepatotoxicityDrug Metabolism Reviews, 2004
- Drug-induced liver diseaseCurrent Opinion in Gastroenterology, 2002
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993